Millie
your market intelligence analyst
Search Results
110 results
Your search is now limited to «Clinical Trials» expert search.
PR Newswire 07/18/2019 16:00
A rapid improvement in clinical outcome was observed in patients treated with PMZ-1620.
More from PR Newswire:
GlobeNewswire 07/18/2019 08:30
MyoKardia is also developing mavacamten in a second indication, non-obstructive HCM, in the Phase 2 MAVERICK-HCM clinical trial.
More from GlobeNewswire:
ClinicalTrials.gov 07/18/2019 07:49
The only additional step due to the participation of the study is that wearing the ring device and Holter monitoring device during their daily lives until the next outpatient clinic.
More from ClinicalTrials.gov:
Benzinga 07/15/2019 07:30
By directly activating cardiac myosin, treatment with omecamtiv mecarbil may represent a novel therapeutic strategy to increase cardiac muscle function in heart failure patients with reduced ejection fraction, potentially leading to improved clinical outcomes.
More from Benzinga:
FeedNavigator (EU) 07/12/2019 02:52
No summary found
More from FeedNavigator (EU):
Hemophilia News Today 07/10/2019 08:00
The oral presentation was titled “ Initial results of the Alta study, a phase 1/2, open label, adaptive, dose-ranging study to assess the safety and tolerability of SB-525 gene therapy in adult subjects with hemophilia A.
More from Hemophilia News Today:
Business Wire 07/08/2019 02:00
Hence, the study reinforces Takeda’s leadership in advancing treatment for hemophilia A, which also includes a comprehensive gene therapy clinical trial program,” said Dr. med.
More from Business Wire:
Pulmonary Hypertension News 07/03/2019 08:00
Into the vein (intravenous) injections of Revatio (sildenafil) have no added benefit over inhaled nitric oxide (iNO) used alone in treating newborns with persistent pulmonary hypertension (PPHN), a Phase 3 trial sponsored by Pfizer shows.
More from Pulmonary Hypertension News:
Healio News 06/21/2019 11:38
In case you missed some of our live coverage of the National Kidney Foundation Spring Clinical Meetings last month, Healio/Nephrology has compiled five of the most popular stories.
More from Healio News:
Seeking Alpha 05/24/2019 09:29
Phase 3 trials enroll a larger number of patients than Phase 2 trials, which could cause problems to show up, or show that prior positive Phase 2 results were false positives.
More from Seeking Alpha:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications